Poland registry of procedures to open completely blocked coronary arteries (chronic total occlusions)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, national multicenter registry enrolling adults undergoing CTO PCI as part of routine care at participating Polish hospitals. Investigators will collect detailed clinical, procedural, intravascular imaging, biomarker, and follow-up data to measure procedural success, periprocedural complications, and longer-term outcomes. The registry will compare different procedural strategies and devices (for example intravascular imaging use, drug-coated balloons, drug-eluting stents, hybrid techniques) and will examine the safety of PCI performed with mechanical circulatory support. Artificial intelligence–based analyses will be applied to the collected data to try to predict clinical outcomes and patient-reported quality-of-life after CTO PCI.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing CTO PCI based on clinical grounds

Exclusion Criteria:

* Age \<18 years
* Patient's refusal to participate in the registry

Where it's running

• Medical University of Białystok
  Bialystok, Poland Recruiting
• Szpital Zachodni
  Grodzisk Mazowiecki, Poland Recruiting
• Specialist Hospital in Inowrocław
  Inowrocław, Poland Recruiting
• Medical University of Silesia
  Katowice, Poland Recruiting
• Institute of Cardiology
  Krakow, Poland Recruiting
• St. John Paul II Hospital
  Krakow, Poland Recruiting

Study contacts

• Study coordinator: Maksymilian Opolski, MD, PhD
• Email: mopolski@ikard.pl
• Phone: 0048223434127

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two ways to open chronic total coronary artery blockages: antegrade dissection-and-reentry versus retrograde approach.

  This test will compare whether the antegrade dissection-and-reentry or the retrograde approach works better and is safer for people with difficult chronic total coronary occlusions who need PCI.

  Recruiting at 3 sites National Institute of Cardiology, Warsaw, Poland · Warsaw, Warsaw and 2 other locations · NCT06878729

• Pilates breathing vs diaphragmatic breathing after PCI

  This study tests whether Pilates breathing or diaphragmatic breathing helps improve oxygen levels and heart-rate variability in people who just had PCI.

  Recruiting Foundation University Islamabad · Rawalpindi · NCT07872098

• Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI

  This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.

  Recruiting Jilin University · Changchun, Jilin · NCT07846462

• PCI Registry at University Hospital Basel for Complex Coronary Procedures

  This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07814157

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Dual antihypertensive combinations after PCI: ARB + thiazide versus ARB + amlodipine

  This trial tests two blood pressure treatment combos after a stent procedure in people with hypertension and coronary disease to see which regimen better controls blood pressure and improves symptoms.

  Recruiting National Medical Research Center for Therapy and Preventive Medicine · Moscow · NCT07683585

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.